Gönczi Lóránt, Végh Zsuzsanna, Golovics Petra Anna, Rutka Mariann, Gecse Krisztina Barbara, Bor Renáta, . . . Papp Mária. (2017). Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
Chicago Style (17th ed.) CitationGönczi Lóránt, et al. Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical and Biochemical Markers Play a More Important Role? 2017.
MLA idézésGönczi Lóránt, et al. Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical and Biochemical Markers Play a More Important Role? 2017.